Longevity is moving beyond “living longer” and becoming the business of preserving human capability

The developments shaping September 7, 2026 point towards a transformation much larger than the conventional conversation around ageing. Science is beginning to intervene experimentally in mechanisms associated with ageing; cognitive prevention is moving years before the first symptoms of decline; primary care is testing digital tools against frailty; artificial intelligence is entering care, health and retirement; governments are beginning to confront ageism and digital exclusion; and mature consumers control an increasingly important share of global purchasing power. These developments point in the same direction: the Longevity Economy is moving away from being organised around how many years people live and towards how many of those years they can preserve physical, cognitive, financial and social capability.

One of the studies continuing to dominate the scientific conversation is the Nature research involving semaglutide. When administered to older female mice, the intervention extended median survival and improved several processes associated with ageing, physical function and metabolism. The boundary must remain clear: this is animal research and does not demonstrate that Ozempic, Wegovy or semaglutide extend human lifespan or justify their use as longevity treatments in healthy people. Nevertheless, the findings substantially broaden the scientific question surrounding GLP-1 medicines. If future human research identifies effects on multimorbidity, frailty or functional preservation, the enormous market created around obesity and diabetes could expand into geroscience and healthy longevity. For pharma and biotech, this could mean moving from treating individual diseases towards investigating medicines capable of influencing multiple mechanisms associated with ageing.

Cognitive prevention is moving in an equally interesting direction. Programmes implemented across 11 Latin American countries have combined physical activity, healthy nutrition, cognitive training and social engagement among older people at risk of cognitive decline. Participants receiving structured interventions and support achieved stronger cognitive outcomes than those receiving general recommendations. The business lesson extends beyond the clinical findings: knowing what to do is not the same as actually doing it. Value may increasingly lie in adherence, monitoring, coaching and personalisation. For insurers, longevity clinics, Senior Living operators and digital platforms, this creates a model based not merely on recommending exercise or healthy eating but on actively supporting behaviour over many years.

Something similar is beginning to happen with frailty. A study published on September 6 evaluated DIALOR, a digital platform combined with health coaching for people aged 65+ with mild-to-moderate frailty and additional health conditions. Participants had a mean age of 77, and the intervention proved feasible and acceptable, although larger trials will be required to establish clinical effectiveness and cost-effectiveness. The business opportunity lies in the architecture: technology supporting healthcare professionals rather than attempting to replace them. AgeTech may find its largest opportunity in continuous monitoring between consultations, detecting functional changes and allowing doctors, nurses and caregivers to support far larger populations without increasing human resources at the same rate. People + technology + longitudinal data could become one of the dominant care models in ageing societies.

Artificial intelligence adds another dimension. AI is entering loneliness support, medical-appointment preparation, home monitoring, risk detection, fall prevention, financial planning and caregiver assistance. At the same time, a question is emerging that could become one of the major regulatory debates within the Silver Economy: which decisions can safely be delegated to algorithms when the person receiving those recommendations may be vulnerable? South Korea is increasingly positioning itself around age-inclusive AI, arguing that older adults should participate directly in the design and testing of systems intended for them and that sensitive decisions should retain human oversight. For banks, insurers, healthcare systems, governments and AgeTech companies, it may soon be insufficient to say that a product uses AI. Organisations will need to demonstrate that it works effectively for people aged 65, 75, 85 or 95, does not discriminate by age and preserves autonomy and decision-making capacity.

Spain is simultaneously bringing workplace ageism into the political debate. A proposal in Mallorca has highlighted the gap between the large proportion of unemployed people over 50 and their much smaller share of new hires, while advocating recruitment incentives, continuous digital training and intergenerational mentoring. For Human Resources, there is an obvious strategic contradiction: many companies report talent shortages while overlooking professionals with decades of accumulated expertise. In an economy where careers may extend to 65, 70 or beyond, 50+ reskilling, phased retirement, mentoring and multigenerational teams can become competitive tools, particularly as artificial intelligence enables experienced professionals to combine accumulated judgement with new technological capabilities.

The Canary Islands is also addressing another increasingly important issue: digital inclusion as a condition for full participation in society. Proposed legislation on older people’s participation and intergenerational solidarity includes digital inclusion, an ageing observatory and housing models oriented towards greater independence. The message for businesses is important. As banking, government, healthcare, transport and commerce become digital by default, an interface that a 75-year-old cannot use is no longer simply poor customer experience. It can become a barrier to exercising rights, managing wealth or accessing essential services. Universal design and age-inclusive UX may gradually move from commercial advantage to regulatory expectation.

Science is adding another fundamental piece to the puzzle. Longitudinal research tracking thousands of genes and metabolites shows that two people with the same chronological age can follow very different biological trajectories. Genetics, environment, behaviour and other influences interact over decades to produce different patterns of ageing. This progressively weakens the future of generic “over-50” products and strengthens the case for precision longevity. The next step may not be receiving a single number labelled “biological age”, but understanding which specific systems — metabolic, cardiovascular, muscular, immune or cognitive — are deteriorating fastest in each individual and targeting them through nutrition, exercise, prevention, diagnostics and monitoring.

All of this coincides with an even larger economic transformation. Mature generations control a growing share of global consumption, while a 60- or 65-year-old may still have twenty, thirty or even forty years of economic decisions ahead. They can travel, buy luxury, purchase technology, renovate homes, study, invest, start businesses, buy insurance and spend increasing amounts on preserving health. The 50+ consumer is no longer the end of the customer journey and could become one of the highest lifetime-value customers in the entire economy. This requires a rethink of marketing strategies that remain disproportionately focused on acquiring younger consumers while overlooking generations with greater wealth, more time and potentially decades of future engagement with brands.

The idea connecting the developments of September 7, 2026 can therefore be summarised in one word: capability. Science is trying to preserve biological capability; prevention programmes, cognitive capability; AgeTech, functional capability; artificial intelligence, autonomy; anti-ageism policies, professional capability; and the Silver Economy, economic and consumer capability. For decades, ageing was measured by asking how long someone lived. The next generation of companies will increasingly ask how many of those years a person can continue walking, thinking, working, travelling, making decisions, living independently and consuming.

For boards and senior executives, the implication is enormous. Every additional year of preserved capability can reduce healthcare and care expenditure while simultaneously extending employment, consumption, investment, tourism and economic participation. This is why longevity is moving beyond healthcare and becoming a horizontal transformation across almost every market. The great business opportunity of the twenty-first century may not simply be helping people live longer. It may be something far more valuable: helping people remain themselves for longer.

Lead the new Longevity Economy

The FIFTIERS MBA in Longevity Business is designed for executives, entrepreneurs and investors seeking to understand how longer lives are transforming healthcare, technology, Real Estate, financial services, consumer markets, work and new business models.